CAPITOL COUNSEL LLC

Lobbying for CURIUM · Pharmaceutical manufacturing.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Missouri · Senate · $40,000.00 income · posted Jul 10, 2026

Lobbying activity 1

Pharmacy

Issues regarding radiopharmaceutical New Drug Application (NDA) approvals.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem